25 November 2024
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial First and only…
Blenrep combinations accepted for review by the US FDA for the treatment of relapsed/refractory multiple myeloma · Regulatory submission supported by phase III head-to-head DREAMM-7 and…
22 November 2024
FW Thorpe Plc Annual General Meeting statement At the Annual General Meeting of FW Thorpe Plc, held at 3.15pm 21 November 2024, Chairman, Mike…
20 November 2024
Renold plc (“Renold”, the “Company” or, together with its subsidiaries, the “Group”) Interim results for the half year ended 30 September 2024 Resilient trading; improved…
HICL Infrastructure PLC Interim Results For The Six Months Ended 30 September 2024 Highlights 1. Defined as the return on the portfolio that includes the…
19 November 2024
LONDONMETRIC PROPERTY PLC LONDONMETRIC CONTINUES CAPITAL REYCLING SELLING £58 MILLION OF NON CORE ASSETS AND ACQUIRING A RETAIL PARK FOR £10 MILLION LondonMetric Property…
Rockwood Strategic Plc (“RKW or the “Company”) Interim results for the six months to 30 September 2024 Rockwood Strategic Plc (LSE: RKW) is pleased…
The Edinburgh Investment Trust plc HALF-YEARLY FINANCIAL REPORT FOR THE SIX MONTHS TO 30 SEPTEMBER 2024 19 November 2024 – The Directors of the Edinburgh…